跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,226 条关于
“RBC”
全部
2,226
临床试验
1,356
药物
583
机构
22
资讯
265
2年前
Imetelstat Shows Durable Transfusion Independence in Lower-Risk MDS
去年
RBC Capital Raises Xenon Pharmaceuticals Price Target to $57 Based on Phase III Epilepsy Drug Optimism
去年
Biohaven Withdraws EU Application for Troriluzole in Spinocerebellar Ataxia, RBC Remains Optimistic
去年
Luspatercept Demonstrates Significant Reduction in Transfusion Burden in Lower-Risk MDS Patients: COMMANDS Trial
去年
Study Reveals Different Effects of CLL Therapies on Blood Cell Behavior: Ibrutinib Shows Promise in Normalizing RBC Aggregation
去年
RBC's Insights on Biotech Stocks: Top Investor Questions Answered
4个月前
Scarlet Therapeutics Achieves Breakthrough with Lab-Grown Universal Red Blood Cells Matching Donor Cell Survival
去年
European Commission Approves Imetelstat for Transfusion-Dependent Anemia in Lower-Risk MDS
去年
MAXILUS Trial Investigates Higher Luspatercept Dose in Lower-Risk MDS
去年
Tranexamic Acid Fails to Reduce Transfusions in Radical Cystectomy: TACT Trial
第 1 页,共 27 页
上一页
下一页